carboplatin/pralatrexate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for carboplatin/pralatrexate, covering 2018-01-19 to 2018-01-19. Get the full timeline:
Most recent: Clinical Trial Update: Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer [Phase 1, Phase 2]